![]() |
Volumn 95, Issue 1, 2005, Pages 181-182
|
The hunt for pink Viagra
|
Author keywords
[No Author keywords available]
|
Indexed keywords
APOMORPHINE;
ESTROGEN;
PHOSPHODIESTERASE INHIBITOR;
SILDENAFIL;
TADALAFIL;
TESTOSTERONE;
UNCLASSIFIED DRUG;
VARDENAFIL;
AROUSAL;
BLOOD FLOW;
CLINICAL TRIAL;
CLITORIS;
DRUG COST;
DRUG INDUSTRY;
DRUG MARKETING;
DRUG RESEARCH;
ERECTILE DYSFUNCTION;
FEMALE SEXUAL DYSFUNCTION;
HORMONE SUBSTITUTION;
HUMAN;
PRIORITY JOURNAL;
PROFIT;
REVIEW;
SYNCOPE;
CLINICAL STUDY;
DRUG DEVELOPMENT;
DRUG EFFICACY;
ECONOMIC EVALUATION;
IDIOPATHIC DISEASE;
PATHOPHYSIOLOGY;
PREVALENCE;
RISK BENEFIT ANALYSIS;
SHORT SURVEY;
DRUG DESIGN;
DRUG INDUSTRY;
FEMALE;
HUMANS;
MARKETING;
PIPERAZINES;
PRESCRIPTIONS, DRUG;
SEXUAL DYSFUNCTION, PHYSIOLOGICAL;
VASODILATOR AGENTS;
|
EID: 12544255779
PISSN: 14644096
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1464-410X.2005.05273.x Document Type: Review |
Times cited : (4)
|
References (0)
|